New wildlife feeding ban takes effect in WA amid concerns of CWD
This decision comes as a precautionary measure to mitigate the risk of transmitting Chronic Wasting Disease, an always-fatal neurological disease that affects cervids, among Washington's wildlife populations.
The rule was formed in response to the discovery of CWD in Eastern Washington for the first time in 2024. With no known cure for this disease, state officials identified the need to reduce concentrations of cervids at feeding sites, which could accelerate the spread of this and other wildlife diseases.
Kyle Garrison, an ungulate specialist from the WDFW, emphasized the dangers of wildlife congregations due to feeding practices during a hearing on March 18.
"Artificially increasing cervid concentrations raises the potential for disease transmission. When CWD is present, feeding can facilitate frequent exposure to prions through animal contact and contaminated sites," he explained.
The regulations apply not only to direct feeding, but another rule change March 24 also restricts baiting animals during hunting, both because of CWD.
Public feedback during the hearing revealed a mix of support and skepticism surrounding the new regulations. Out of 453 comments received, many attendees expressed agreement with the ban, understanding its necessity in limiting the potentially devastating impacts of CWD.
However, some voiced concerns about whether the science behind the regulations was robust enough, noting that deer, elk, and moose are social animals that naturally aggregate.
Others had concerns around potential economic impacts related to hunting and wildlife tourism in regions where these practices were previously common.
Despite the mixed reactions, WDFW officials reiterated that feeding wildlife is neither biologically necessary for survival nor beneficial for their health. The ban, according to WDFW, is a step in promoting the overall wellness of Washington's wildlife populations, particularly in light of the threats posed by diseases like CWD.
The health risks associated with wildlife feeding extend beyond disease transmission. Animals accustomed to human-provided food may venture onto roads or become more exposed to predators, according to WDFW.
The digestive systems of these animals are not equipped to handle non-natural foods, with diets involving fruit and grains leading to health complications like rumen acidosis, a metabolic disorder caused by a sudden dietary shift, according to WDFW.
WDFW encourages the public to support wildlife through habitat preservation rather than feeding.
To this end, the agency is promoting its Habitat at Home program, which offers tips for creating natural environments that support wildlife year-round. Residents are also urged to report sightings of sick or injured animals to help monitor health-related issues within wildlife populations.
"I realize this change may be difficult for those who enjoy feeding local wildlife, but the practice is not biologically necessary for these animals to survive," Garrison said. "Ceasing feeding is a significant way for the public to help minimize the impacts of CWD in our state."
What is Chronic Wasting Disease?
Chronic wasting disease is a fatal neurologic illness of cervids, which include deer, elk, moose and caribou. CWD is caused by an infectious prion protein and transmitted from animal to animal through feces, saliva, urine or through contaminated environments.
Most animals with CWD appear normal until the end stages of the disease when they show signs of weight loss, lethargy, drooping ears, excessive salivation and urination and loss of fear of people.
There is no cure for CWD, and testing tissue collected from the head of carcasses is the only way to determine if an animal is infected with it.
SOURCE/WDFW
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
07-08-2025
- Yahoo
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. AT&T to pay $177 million in data breach settlement. Here's how to claim up to $5,000 Wells Fargo is rolling out company wide AI. It says everyone from branch tellers to investment bankers will benefit Want to get smarter? Neuroscience says 5 simple steps significantly boost memory, learning, and cognition Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock, although IPO calendar websites say the listing is expected this week. The company declined to comment on the timeline when reached by Fast Company. This post originally appeared at to get the Fast Company newsletter: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Boston Globe
05-08-2025
- Boston Globe
Congress should reauthorize Hospital-at-Home
Advertisement Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up The Congressional Budget Office scored the Hospital-at-Home Program as Advertisement But these programs are at risk if Congress doesn't act. That's because the at-home experiment was only possible because in 2020, during the COVID-19 pandemic, the Centers for Medicare and Medicaid Services issued a waiver requiring Medicare to reimburse for Hospital-at-Home care at the same rate as inpatient care. The waiver also let states reimburse via Medicaid, and Massachusetts is one of around a dozen states where Medicaid pays the same rate for at-home and inpatient care, according to the American Hospital Association. The waiver was extended in 2022 and 2024. Federal regulators have approved Hospital-at-Home programs Now, though, the waiver is set to expire Sept. 30, unless Congress approves a Constantinos Michaelidis, medical director of Hospital at Home at UMass Memorial Health, said UMass started the program in August 2021 when patients were waiting hours for a hospital bed. Since then, around 3,600 patients have been cared for at home after presenting at one of three hospitals. According to data provided by UMass Memorial, compared to patients using its brick-and-mortar hospitals, Hospital-at-Home patients had 60 to 70 percent lower mortality, 15 to 30 percent higher patient satisfaction, 5 to 15 percent fewer readmissions, and 80 to 90 percent fewer transfers to skilled nursing facilities after discharge. Michaelidis said he wants to eventually offer Hospital-at-Home throughout the system, and a five-year extension would provide the financial certainty to expand. 'These programs take a lot of money to get off the ground,' Michaelidis said. 'We need Congress to make sure if we spend $3 million expanding the program, it won't go away in two months.' Advertisement A similar calculation is underway at Beth Israel Lahey Health, which started offering Hospital-at-Home in August 2023 at Lahey Hospital and Medical Center. The program has grown gradually, as specialists in different fields established protocols for who can be served at home. It now admits around 100 patients a month, and the hospital recently started offering physical therapy virtually to at-home patients. Sue Stempek, vice president of BILH Hospital at Home, said the system is considering expanding the program to additional hospitals, and a long-term waiver would allow for growth and for research studies to evaluate the model's effectiveness. An open question is the cost impact. Today in Massachusetts, some commercial insurers pay inpatient rates; some pay less. Lora Pellegrini, president of the Massachusetts Association of Health Plans, said some insurers balk at paying inpatient rates when home care doesn't have the same overhead costs. But hospital officials say start-up costs are hefty for staff, equipment, and technology. South Shore Health closed its Hospital-at-Home program May 17, after 11 months. Chief of Medicine Jason Tracy said participants loved the program. But it took time for patients and clinicians to adjust to the idea, and when serving only five or six patients a day, the program lost millions of dollars. 'In this environment, you have to put your resources toward stronger financially performing programs that have greater patient demand,' Tracy said. There are efficiencies in bigger hospital systems. Mass General Brigham has treated over 7,000 patients since January 2022 in Hospital-at-Home programs run through five hospitals. The health system saved 35,000 'bed days,' a measure of how many days inpatient beds would have been filled by those patients. Advertisement Heather O'Sullivan, MGB's president of Healthcare at Home, said the program has expanded to new patient populations — like those in post-operative recovery — and the federal waiver lets the hospital scale up knowing it can recoup costs. Without the waiver, O'Sullivan worried that all but the largest health systems would be unable to make those investments. Congress should also ask federal regulators to study the costs associated with Hospital-at-Home, to determine whether insurance should continue to pay the same as for inpatient care or whether home hospital can achieve cost savings. The need to study costs shouldn't prevent Congress from reauthorizing the waiver for five years, though. Hospital-at-Home provides the care patients want with improved health outcomes, while preserving beds for patients who need inpatient care. That's a win-win-win. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Fox News
23-07-2025
- Fox News
At-home test works like coffee rings to spot serious illness faster
Have you ever noticed how a spilled cup of coffee leaves behind a telltale brown ring? While those stains might be annoying, the science behind them, known as the coffee ring effect, has sparked innovations in health technology. UC Berkeley researchers recently turned this everyday phenomenon into a breakthrough medical test, making rapid and reliable disease detection as easy as brewing your morning coffee. Curious how a simple coffee stain could inspire cutting-edge diagnostics and revolutionize at-home testing? Let's look at how a forgotten mug on your desk might just save lives. Ever wondered why spilled coffee, wine or tea dries in a ring rather than evenly? This common pattern is known as the "coffee ring effect." The phenomenon occurs because of the liquid's surface tension. As the drop begins to dry, water at the edges evaporates more quickly since that area is thinner. To keep up, liquid from the center flows outward, carrying tiny particles with it. Once the drop is completely dry, these particles settle along the edge, creating the signature ring stain you see on tables and countertops every day. Surprisingly, that annoying coffee ring on your table has inspired a major breakthrough in medical technology. Researchers at UC Berkeley transformed this everyday nuisance into a powerful new at-home diagnostic test. This innovative test can identify diseases like COVID-19, prostate cancer and sepsis with remarkable accuracy. In fact, it is up to 100 times more sensitive than many current rapid tests. Even better, it delivers results in just twelve minutes, depending on the test. The idea began with Kamyar Behrouzi, a former Ph.D. student at UC Berkeley. While developing a COVID-19 biosensor in 2020, he noticed that virus particles, much like coffee particles, tend to gather at the edge of a droplet. By using this natural effect, the researchers designed a test that captures and concentrates disease markers, making detection much easier. Thanks to this stain-inspired science, fast and reliable testing is now possible right at home. So, how does this innovative test actually work? First, you place a small sample from your nose or cheek onto a special membrane. As the sample dries, disease proteins concentrate at the edges to form a visible ring. Next, you add a second droplet containing light-reactive particles. If certain disease biomarkers are present, these nanoparticles light up when exposed to light. You can see positive results with the naked eye in some cases, or verify them more accurately using a special AI-powered smartphone app. This rapid test does more than detect COVID-19. It can also identify early signs of sepsis, a life-threatening infection that needs quick treatment. To make home testing accessible, the UC Berkeley team even created a 3D-printed prototype for easy use on your kitchen counter. According to professor Liwei Lin, this innovative approach could transform regular health screening, with no lab visit required. This coffee ring-inspired test brings hospital-level disease detection right to your home. With results ready in under twelve minutes, you can quickly check for diseases like COVID-19 and even early signs of sepsis. You no longer need to schedule lab visits or wait days for results. Instead, you can take charge of your health from the comfort of your kitchen, using a simple, affordable tool that could catch problems early and help keep your family safe. As technology like this becomes widely available, routine screening could become as easy as making your morning coffee. It's incredible how a common coffee stain inspired a breakthrough in medical testing. Science proves that even life's little messes can spark big innovations. With these advances, you can look forward to faster, easier health checks at home and maybe appreciate your next coffee spill just a little more. Would you trust a coffee stain to help catch disease early? Let us know by writing us at Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts, and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide - free when you join my Copyright 2025 All rights reserved.
